Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €15.00 EUR
Change Today 0.00 / 0.00%
Volume 0.0
MSTY On Other Exchanges
EN Paris
As of 12:30 PM 04/7/14 All times are local (Market data is delayed by at least 15 minutes).

mainstay medical internation (MSTY) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/3/14 - €20.33
52 Week Low
02/4/15 - €13.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

mainstay medical internation (MSTY) Related Businessweek News

No Related Businessweek News Found

mainstay medical internation (MSTY) Details

Mainstay Medical International plc, together with its subsidiaries, operates as a medical device company in the United States and Australia. It develops ReActiv8, an active implantable medical device for the treatment of people with chronic low back pain, which is in clinical trials. This device primarily serves individuals, families, communities, industries, and governments. The company was formerly known as Mainstay Medical plc and changed its name to Mainstay Medical International plc in March 2014. Mainstay Medical International plc was founded in 2008 and is headquartered in Swords, Ireland.

17 Employees
Last Reported Date: 03/19/15
Founded in 2008

mainstay medical internation (MSTY) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $400.2K
Compensation as of Fiscal Year 2013.

mainstay medical internation (MSTY) Key Developments

Mainstay Medical International plc Presents at Bio-Trinity, May-13-2015 03:20 PM

Mainstay Medical International plc Presents at Bio-Trinity, May-13-2015 03:20 PM. Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom. Speakers: Peter A. Crosby, Chief Executive Officer, President and Executive Director.

Mainstay Medical International plc Announces Audited Consolidated Earnings Results and Parent Cash Flow Results for the Year Ended December 31, 2014

Mainstay Medical International plc announced audited consolidated earnings results and parent cash flow results for the year ended December 31, 2014. For the year, on consolidated basis, the company reported operating loss of $15,160,000 compared to $8,396,000 a year ago. Loss before income taxes was $82,407,000 compared to $10,286,000 a year ago. Net loss attributable to equity holders were $82,465,000 or $28.09 per share compared to $10,318,000 or $126.76 per share a year ago. Net cash used in operations was $11,444,000 compared to $7,108,000 a year ago. Acquisition of property and equipment was $36,000 compared to $25,000 a year ago. For the year, on parent basis, the company’s net cash used in operations was $3,563,000.

Mainstay Medical International plc to Report Fiscal Year 2014 Results on Mar 19, 2015

Mainstay Medical International plc announced that they will report fiscal year 2014 results at 7:00 AM, GMT Standard Time on Mar 19, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSTY:ID €15.00 EUR 0.00

MSTY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MSTY.
View Industry Companies

Industry Analysis


Industry Average

Valuation MSTY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAINSTAY MEDICAL INTERNATION, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at